WASHINGTON (Reuters) – U.S. regulators will require 16 manufacturers of brand-name and generic opioid painkillers to impose stronger measures to curb misuse and abuse, the U.S. Food and Drug Administration said on Monday.
The FDA sent letters inviting the companies to a meeting in March to discuss ways to reduce dangerous use of the medicines. Companies that received the letters include Johnson & Johnson, King Pharmaceuticals Inc, Endo Pharmaceuticals Holding Inc and privately held Purdue Pharma.
Call us today to discuss how the V.I.P. Way can free you from your opiate dependency and get your life back. Call today: (800)276-7021 or (702)308-6353 Email: info@rapiddetoxlasvegas.com Medical Director: Board-Certified by American Board of Anesthesiology 1994, former chief of cardiac anesthesia, University of Nevada School of Medicine. Board-Certified by American Board of Pain Medicine 1997, Clinical Assistant Professor University Nevada School of Medicine.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment